Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Scientific Reports|October 26, 2022
Real world data on the prognostic significance of monocytopenia in myelodysplastic syndromePanagiotis T Diamantopoulos, Emmanouil Charakopoulos, Argiris Symeonidis, et al.
Leukemia Research|October 2, 2009
Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study GroupNikolaos J Tsagarakis, Nektaria A Kentrou, Konstantinos A Papadimitriou, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 30, 2019
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine RegistryPanagiotis T Diamantopoulos, Vasiliki Pappa, Argiris Symeonidis, et al.
Therapeutic Advances in Hematology|December 21, 2020
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromesSotirios G Papageorgiou, Ioannis Kotsianidis, Anthi Bouchla, et al.
British Journal of Haematology|August 31, 2020
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomesPanagiotis T Diamantopoulos, Argiris Symeonidis, Vasiliki Pappa, et al.
The Journal of Clinical Investigation|April 28, 2015
Mast cells mediate malignant pleural effusion formationAnastasios D Giannou, Antonia Marazioti, Magda Spella, et al.
EMBO Molecular Medicine|December 13, 2021
KRAS signaling in malignant pleural mesotheliomaAntonia Marazioti, Anthi C Krontira, Sabine J Behrend, et al.
Annals of Hematology|February 1, 2021
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategiesTheodoros P Vassilakopoulos, Sotirios G Papageorgiou, Maria K Angelopoulou, et al.
In Vivo (Athens, Greece)|April 28, 2022
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell LymphomaStamatis J Karakatsanis, Maria Bouzani, Argyris Symeonidis, et al.
Pageof 9